967
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Chebulic acid attenuates ischemia reperfusion induced biochemical alteration in diabetic rats

&
Pages 23-29 | Received 02 Apr 2012, Accepted 25 May 2012, Published online: 11 Sep 2012

References

  • Aslan M, Deliorman Orhan D, Orhan N, Sezik E, Yesilada E. (2007). In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats. J Ethnopharmacol, 109, 54–59.
  • Casey RG, Joyce M, Roche-Nagle G, Chen G, Bouchier-Hayes D. (2005). Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease. J Surg Res, 123, 176–181.
  • Chattopadhyay RR. (1999). Possible mechanism of antihyperglycemic effect of Azadirachta indica leaf extract: Part V. J Ethnopharmacol, 67, 373–376.
  • De Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD. (2011). Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med, 171, 412–420.
  • DeFronzo R. (1995). Diabetic nephropathy: Etiologic and therapeutic considerations. Diabetes Rev, 3, 510–564.
  • Dhir A, Kulkarni SK. (2008). Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol Biochem Behav, 89, 563–571.
  • Evans TC, Capell P. (2000). Diabetic nephropathy. Clin Diabetes, 18, 1–11.
  • Gao H, Huang YN, Xu PY, Kawabata J. (2007). Inhibitory effect on α-glucosidase by the fruits of Terminalia chebula Retz. Food Chem, 105, 628–634.
  • Ghosh MN. (2008). Fundamentals of Experimental Pharmacology. Kolkata, India: Hilton and Company.
  • Ha H, Hwang IA, Park JH, Lee HB. (2008). Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract, 82 Suppl 1, S42–S45.
  • Hostetter TH, Troy JL, Brenner BM. (1981). Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int, 19, 410–415.
  • Jovanovic L, Peterson CM. (1981). The clinical utility of glycosylated hemoglobin. Am J Med, 70, 331–338.
  • Kawanishi K, Ishida T, Kajikawa T, Tada S. (1994). [Clinical laboratory tests in diabetes mellitus]. Rinsho Byori, 42, 779–785.
  • Kelly DJ, Allen TJ, Cooper ME. (2000). Experimental diabetic nephropathy: Is it relevant to human disease. Nephrology, 5, 177–185.
  • Klika KD, Saleem A, Sinkkonen J, Kahkonen M, Loponen J, Tahtinen P, Pihlaja K. (2004). The structural and conformational analyses and antioxidant activities of chebulinic acid and its thrice-hydrolyzed derivative, 2,4-chebuloyl-β-d-glucopyranoside, isolated from the fruit of Terminalia chebula. Arkivoc, 7, 83–105.
  • Krishnamurti U, Steffes MW. (2001). Glycohemoglobin: A primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem, 47, 1157–1165.
  • Kumar GPS, Arulselvan P, Kumar DS, Subramanian SP. (2006). Antidiabetic activity of fruits of Terminalia chebula on streptozotocin induced diabetic rats. J Health Sci, 52, 283–291.
  • Kumar GPS, Subramanian SP. (2008). Biochemical studies on the effect of Terminalia chebula on the levels of glycoproteins in streptozotocin induced experimental diabetes in rats. J Appl Biomed, 6, 105–115.
  • Larkins RG, Dunlop ME. (1992). The link between hyperglycaemia and diabetic nephropathy. Diabetologia, 35, 499–504.
  • Lee HS, Jung SH, Yun BS, Lee KW. (2007). Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol, 81, 211–218.
  • Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. (2010). Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol, 131, 567–574.
  • Lee SH, Ryu SY, Choi SU, Lee CO, No Z, Kim SK, Ahn JW. (1995). Hydrolysable tannins and related compound having cytotoxic activity from the fruits of Terminalia chebula. Arch Pharmacal Res, 18, 118–120.
  • Lin TC, Hsu FL, Cheng JT. (1993). Antihypertensive activity of corilagin and chebulinic acid, tannins from Lumnitzera racemosa. J Nat Prod, 56, 629–632.
  • Liu HR, Tang XY, Dai DZ, Dai Y. (2008). Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats. J Ethnopharmacol, 118, 466–472.
  • Maiti R, Jana D, Das UK, Ghosh D. (2004). Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol, 92, 85–91.
  • Melin J, Hellberg O, Akyürek LM, Källskog O, Larsson E, Fellström BC. (1997). Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int, 52, 985–991.
  • Murali YK, Chandra R, Murthy PS. (2004). Antihyperglycemic effect of water extract of dry fruits of Terminalia chebula in experimental diabetes mellitus. Indian J Clin Biochem, 19, 202–204.
  • Naik GH, Priyadarsini KI, Naik DB, Gangabhagirathi R, Mohan H. (2004). Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine, 11, 530–538.
  • Nangle MR, Gibson TM, Cotter MA, Cameron NE. (2006). Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med, 72, 494–500.
  • Pari L, Latha M. (2002). Effect of Cassia auriculata flowers on blood sugar levels, serum and tissue lipids in streptozotocin diabetic rats. Singapore Med J, 43, 617–621.
  • Rabkin R. (2003). Diabetic nephropathy. Clin Cornerstone, 5, 1–11.
  • Randhawa MA. (2009). Calculation of LD50 values from the method of Miller and Tainter, 1944. J Ayub Med Coll Abbottabad, 21, 184–185.
  • Rao NK, Nammi S. (2006). Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement Altern Med, 6, 17.
  • Reddi AS, Camerini-Davalos RA. (1990). Diabetic nephropathy. An update. Arch Intern Med, 150, 31–43.
  • Rossing P, Hommel E, Smidt UM, Parving HH. (1994). Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia, 37, 511–516.
  • Sabu MC, Kuttan R. (2002). Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol, 81, 155–160.
  • Saleem A, Husheem M, Härkönen P, Pihlaja K. (2002). Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol, 81, 327–336.
  • Sharma A, Bhardwaj S, Mann AS, Jain A, Kharya MD. (2007). Screening method of antioxidant activity: An overview. Phcog Rev, 1, 232–238.
  • Sharma S, Kulkarni SK, Chopra K. (2006). Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol, 33, 940–945.
  • Spiro RG, Spiro MJ. (1971). Effect of diabetes on the biosynthesis of the renal glomerular basement membrane. Studies on the glucosyltransferase. Diabetes, 20, 641–648.
  • Steffes MW, Brown DM, Mauer SM. (1978). Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes, 27, 35–41.
  • Suchalatha S, Devi CS. (2005). Protective effect of Terminalia chebula against lysosomal enzyme alterations in isoproterenol-induced cardiac damage in rats. Exp Clin Cardiol, 10, 91–95.
  • Tesch GH, Allen TJ. (2007). Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton), 12, 261–266.
  • Wang H, Gao XD, Zhou GC, Cai L, Yao WB. (2008). In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit. Food Chem, 106, 888–895.
  • Wongmekiat O, Thamprasert K, Lumlertgul D. (2007). Renoprotective effect of trolox against ischaemia-reperfusion injury in rats. Clin Exp Pharmacol Physiol, 34, 753–759.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.